China Resources Pharmaceutical Group Limited (HKG:3320)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
4.500
-0.050 (-1.10%)
Jun 18, 2026, 4:08 PM HKT

HKG:3320 Stock Forecast

Stock Price Forecast

According to 11 analysts polled by S&P Global, HKG:3320 stock has a consensus rating of "Buy" and an average price target of $6.79. The average 1-year stock price forecast is 50.89% higher than the current stock price, while the lowest is $5.90 (+31.11%) and the highest is $7.52 (+67.11%).

Price Target: $6.79 (+50.89%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$5.90$6.79$6.95$7.52
Change+31.11%+50.89%+54.44%+67.11%
* Price targets were last updated on Apr 20, 2026.

Analyst Ratings

The average analyst rating for HKG:3320 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingDec '25Jan '26Feb '26Mar '26Apr '26May '26
Strong Buy666656
Buy444444
Hold111111
Sell111100
Strong Sell000000
Total121212121011

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Unknown Analyst
Guotai Haitong
No rating
Guotai Haitong
Buy
Maintains
$6.82
BuyMaintains$6.82+51.56%Apr 20, 2026
Unknown Analyst
CICC
No rating
CICC
Buy
Maintains
$7.00
BuyMaintains$7.00+55.56%Mar 27, 2026
Unknown Analyst
Nomura
No rating
Nomura
Buy
Maintains
$7.52
BuyMaintains$7.52+67.11%Mar 27, 2026
Unknown Analyst
China Merchants Securities
No rating
China Merchants Securities
Buy
Maintains
$6.30
BuyMaintains$6.30+40.00%Mar 26, 2026
Unknown Analyst
Bank of America Securities
No rating
Bank of America Securities
Buy
Maintains
$5.90
BuyMaintains$5.90+31.11%Mar 25, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
285.94B
from 269.57B
Increased by 6.07%
Revenue Next Year
300.59B
from 285.94B
Increased by 5.12%
EPS This Year
0.69
from 0.64
Increased by 7.90%
EPS Next Year
0.74
from 0.69
Increased by 7.17%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
192.92B218.18B244.70B257.67B269.57B285.94B
Revenue Growth
14.31%13.10%12.16%5.30%4.62%6.07%
Gross Profit
28.82B33.62B38.34B40.69B44.51B47.99B
Gross Margin
14.94%15.41%15.67%15.79%16.51%16.78%
Operating Income
8.02B9.74B11.03B11.98B12.65B14.57B
Net Income
3.07B3.50B3.85B3.35B4.05B4.25B
EPS
----0.640.69
EPS Growth
----28.03%7.90%
Forward PE
5.818.756.117.106.575.63
Dividend / Share
0.120.140.150.140.190.18
Dividend Growth
-15.82%8.81%-12.34%43.70%-6.78%
Free Cash Flow
-2.43B8.34B1.76B-8.59B-1.39B1.56B
No. Analysts
-----11
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.

Revenue Forecast

Revenue202620272028
High294.2B
Avg285.9B
Low282.5B

Revenue Growth

Revenue Growth202620272028
High
9.1%
Avg
6.1%
Low
4.8%

EPS Forecast

EPS202620272028
High-
Avg0.69
Low-

EPS Growth

EPS Growth202620272028
High-
Avg
7.9%
Low-